| Bioactivity | CK0492B is a novel biaminourea antibiotic that has antiplaque properties in vitro and has shown efficacy in an experimental mouse dental disease model. A 12-week study in beagles compared its efficacy in reducing plaque and gingivitis, staining potential, and safety. Dogs were selected as the study subjects because the onset and progression of canine periodontal disease are similar to humans. Chlorhexidine acetate was selected as a positive control for plaque and gingivitis reduction and staining because it is effective in both humans and dogs. |
| CAS | 64169-11-5 |
| Formula | C36H66N10O8S2 |
| Molar Mass | 831.10 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Basic Biological Sciences: Effects of Chlorhexidine and Four Antimicrobial Compounds on Plaque, Gingivitis, and Staining in Beagle Dogs |
CK0492B
CAS: 64169-11-5 F: C36H66N10O8S2 W: 831.10
CK0492B is a novel biaminourea antibiotic that has antiplaque properties in vitro and has shown efficacy in an experimen
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.